- Home
- IMTX vs ECVT Comparison
IMTX vs ECVT Comparison
Compare IMTX & ECVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMTX | ECVT |
|---|---|---|
| Founded | N/A | 1935 |
| Country | Germany | United States |
| Employees | 407 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | IMTX | ECVT |
|---|---|---|
| Price | $10.91 | $14.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $19.00 | $14.00 |
| AVG Volume (30 Days) | 361.6K | ★ 2.7M |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $723,515,000.00 |
| Revenue This Year | N/A | $26.96 |
| Revenue Next Year | $25.91 | $5.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.70 |
| 52 Week Low | $3.94 | $5.68 |
| 52 Week High | $12.41 | $14.42 |
Technical Indicators
Market Signals| Indicator | IMTX | ECVT |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 69.91 |
| Support Level | $9.66 | $8.17 |
| Resistance Level | $11.30 | N/A |
| Average True Range (ATR) | 0.49 | 0.47 |
| MACD | 0.13 | 0.10 |
| Stochastic Oscillator | 88.71 | 77.27 |
Price Performance
Historical ComparisonAbout IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
About ECVT Ecovyst Inc.
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has one operating segment. The Company's single reportable segment, Ecoservices, derives its revenue through the sale of virgin and regenerated sulfuric acid products and services.